Loading...
•
Dec 31, 2025
Embecta Q1 2026 Earnings Report
Embecta Corp. reported its first quarter fiscal 2026 financial results, with revenues largely consistent with expectations and strategic initiatives focused on transforming into a broad-based medical supplies company.
Key Takeaways
Embecta Corp. reported first quarter fiscal 2026 revenues of $261.2 million, a slight decrease of 0.3% on a reported basis compared to the prior year. Net income stood at $44.1 million, with diluted EPS of $0.74. The company maintained its previously provided guidance for key financial reporting metrics, emphasizing strategic initiatives to expand its product portfolio and increase financial flexibility through debt reduction.
Reported revenues for Q1 fiscal 2026 were $261.2 million, a 0.3% decrease on a reported basis and a 2.0% decrease on an adjusted constant currency basis.
Net income for the quarter was $44.1 million, with diluted earnings per share of $0.74, significantly up from $0.0 million and $0.00 in the prior year period.
Adjusted EBITDA for the quarter was $97.2 million, with an adjusted EBITDA margin of 37.2%, consistent with the prior year period.
The company reduced debt by approximately $37.5 million of outstanding principal under its term loan B facility during the quarter.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For fiscal year 2026, Embecta Corp. maintains its previously provided financial guidance, expecting reported revenues between $1,071 million and $1,093 million, and adjusted earnings per diluted share between $2.80 and $3.00.
Positive Outlook
- Maintaining global leadership position in core injection products.
- Expanding product portfolio to serve chronic care patients and drug delivery partners.
- Creating additional financial flexibility through ongoing debt reduction.
- Strengthening U.S. Medicare business by contracting with an additional Medicare Part D payer for exclusive access.
- Advancing over one third of identified potential B2B generic partners into contract negotiations or executed contracts.
Challenges Ahead
- Competitive factors could adversely affect operations.
- Inability to replace services provided by BD under transaction documents.
- Failure by BD to perform its obligations under separation agreements.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...